Cardano Risk Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202M Buy
772,791
+203,776
+36% +$52.2M 1.11% 20
2026
Q2
$143M Buy
569,015
+32,345
+6% +$6.96M 1.1% 26
2026
Q1
$124M Sell
536,670
-7,823
-1% -$1.74M 1.22% 22
2025
Q4
$124M Buy
544,493
+7,823
+1% +$1.78M 1.25% 20
2025
Q3
$124M Buy
536,670
+12,629
+2% +$2.57M 1.32% 20
2025
Q2
$97.3M Buy
524,041
+30,204
+6% +$5.61M 1.25% 25
2025
Q1
$103M Buy
+493,837
New +$96M 1.65% 19

Other funds holding ABBV

Cardano Risk Management's ABBV Position: Q3 2026 in Review

Cardano Risk Management increased its AbbVie (ABBV) stake by 36% in Q3 2026, buying an estimated $52.2M and bringing the position to 772,791 shares worth $202M. The position accounts for 1.11% of the portfolio, ranked #20.

Cardano Risk Management first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. 4,245 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cardano Risk Management held 772,791 shares of AbbVie worth $202M as of Q3 2026.
  • Cardano Risk Management bought 203,776 AbbVie shares in Q3 2026, an estimated $52.2M.
  • AbbVie made up 1.11% of Cardano Risk Management's portfolio in Q3 2026, its #20 holding.
  • Cardano Risk Management first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
  • 4,245 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cardano Risk Management's 13F filing for Q3 2026, filed 20 Oct 2026.